Hydrocortisone and Acetic Acid

Dosage Form: otic solution

Hydrocortisone and Acetic Acid Otic Solution, USP

Hydrocortisone and Acetic Acid Description

Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing propylene glycol diacetate (3%), benzethonium chloride (0.02%), sodium acetate (0.015%) and citric acid (0.05%). The empirical formulas for acetic acid and hydrocortisone are CH3COOH, and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are:

Slideshow: View Frightful (But Dead Serious) Drug Side Effects

Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

Hydrocortisone and Acetic Acid - Clinical Pharmacology

Acetic acid is antibacterial and antifungal; hydrocortisone is antiinflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

Indications and Usage for Hydrocortisone and Acetic Acid

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Contraindications

Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Warnings

Discontinue promptly if sensitization or irritation occurs.

Precautions

Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

PEDIATRIC USE

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

Adverse Reactions

Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

Hydrocortisone and Acetic Acid Dosage and Administration

Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

How is Hydrocortisone and Acetic Acid Supplied

Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 50383-901-10).

STORAGE

Store at room temperature, 20°- 25°C (68°-77°F). Keep container tightly closed.

Rx only

 

Hi-Tech Pharmacal Co., Inc.

Amityville, NY 11701


Rev. 901:01 5/09

MG# 25405

PRINCIPAL DISPLAY PANEL

NDC 50383-901-10

Hydrocortisone and Acetic Acid Otic Solution, USP

10 mL

Rx only

Hydrocortisone and Acetic Acid 
Hydrocortisone and Acetic Acid solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:50383-901
Route of Administration AURICULAR (OTIC) DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACETIC ACID (ACETIC ACID) ACETIC ACID 20.75 mg  in 1 mL
HYDROCORTISONE (HYDROCORTISONE) HYDROCORTISONE 10.375 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS CITRIC ACID  
BENZETHONIUM CHLORIDE  
PROPYLENE GLYCOL  
PROPYLENE GLYCOL DIACETATE  
SODIUM ACETATE  
Packaging
# Item Code Package Description
1 NDC:50383-901-10 1 BOTTLE, DROPPER in 1 CARTON
1 10 mL in 1 BOTTLE, DROPPER
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA012770 06/04/2009
Labeler - Hi-Tech Pharmacal Co., Inc. (101196749)
Revised: 08/2012
 
Hi-Tech Pharmacal Co., Inc.

More about acetic acid/hydrocortisone otic

Consumer resources

Professional resources

Related treatment guides

Hide
(web4)